14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 AGIO stock ended at $33.22. This is 3.82% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.72% from a day low at $33.21 to a day high of $35.11.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Jul 27, 2020 $51.32 $52.91 $51.32 $52.78 357 417
Jul 24, 2020 $51.59 $51.59 $49.90 $50.80 590 906
Jul 23, 2020 $52.64 $54.17 $51.95 $52.18 382 016
Jul 22, 2020 $53.94 $54.78 $52.57 $53.02 238 300
Jul 21, 2020 $55.95 $56.22 $53.70 $54.01 292 400
Jul 20, 2020 $54.39 $55.97 $53.92 $55.93 474 300
Jul 17, 2020 $51.92 $54.16 $51.43 $53.60 445 500
Jul 16, 2020 $51.65 $52.19 $50.56 $51.87 379 700
Jul 15, 2020 $51.60 $52.41 $50.88 $52.19 293 800
Jul 14, 2020 $50.40 $50.98 $48.18 $50.81 756 900
Jul 13, 2020 $53.03 $53.50 $50.40 $50.40 324 400
Jul 10, 2020 $53.07 $54.08 $52.63 $52.90 300 600
Jul 09, 2020 $55.13 $55.24 $52.45 $53.36 924 900
Jul 08, 2020 $54.65 $55.74 $54.24 $54.86 501 900
Jul 07, 2020 $54.74 $56.03 $53.77 $54.33 549 500
Jul 06, 2020 $56.20 $56.20 $54.13 $54.85 1 268 900
Jul 02, 2020 $56.09 $56.75 $55.09 $55.69 678 452
Jul 01, 2020 $53.68 $56.31 $53.24 $55.64 642 008
Jun 30, 2020 $52.88 $53.65 $51.82 $53.48 541 955
Jun 29, 2020 $51.82 $53.84 $50.93 $53.02 475 107
Jun 26, 2020 $52.61 $52.76 $50.91 $51.71 661 798
Jun 25, 2020 $50.50 $52.93 $50.30 $52.93 425 393
Jun 24, 2020 $51.61 $53.49 $50.50 $50.51 508 242
Jun 23, 2020 $48.90 $52.23 $48.59 $51.87 651 415
Jun 22, 2020 $47.93 $49.26 $46.59 $48.22 1 029 673
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT